+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

IVD in China, South Korea and Vietnam: 2018 Regional Report Bundle

  • ID: 4663088
  • Report
  • September 2018
  • Region: China, South Korea, Vietnam
  • 185 Pages
  • Kalorama Information
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton, Dickinson & Co.
  • Danaher Corp.
  • Horiba Medical
  • MedMira
  • PerkinElmer
  • MORE

This Market Research Bundles allow customers to experience savings while obtaining a large amount of research on topics of importance. This bundle is a combination of 3 complete in vitro diagnostics (IVD) reports, including the following:

  • IVD in China
  • The IVD Market in South Korea
  • The IVD Market in Vietnam

Each report is designed to provide an overview of the IVD market in its respective country, and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:

  • Clinical Chemistry
  • Immunoassays
  • Microbiology and Molecular Testing
  • Point-of-Care (POC) Testing
  • Histology/Cytology

The market data presented provide an overview of developments in the in vitro diagnostics industry in China, South Korea and Vietnam, including the following:

  • In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
  • In Vitro Diagnostic Sales by Broad Market Segment, 2017-2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)

The reports look at China, South Korea and Vietnam in vitro diagnostic sales by broad market segments, comprising clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology:

  • Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis), 2017-2022
  • Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017-222
  • Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2017-2022
  • POC Market Value by Segment (Glucose, Infectious Disease, Other), 2017-2022
  • Histology Market (HPV, CTC, Others), 2017-2022

Also included in the reports are trends influencing the industry and country-level data, including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

This bundle represents the separate report PDFs, exactly as they were published, combined into one. A separate Table of Contents is included for each report in this bundle.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton, Dickinson & Co.
  • Danaher Corp.
  • Horiba Medical
  • MedMira
  • PerkinElmer
  • MORE

IVD IN CHINA

Chapter One: Executive Summary

  • Introduction
    • Figure 1-1: Market Drivers and Restraints: IVD Market in China
  • Scope and Methodology
  • Major Findings of the Report
  • IVD Market in China
    • Figure 1-2: China IVD Market, 2017 and 2022 ($ millions)

Chapter Two: China in Context

  • Overview
    • Figure 2-1 : China IVD Market vs. China Medical Device Market, 2017-2022
    • Figure 2-2 : China Market Dynamics
  • Population Trends
    • Table 2-1: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
    • Figure 2-3 : Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
    • Figure 2-4: Total Number of Births in China by Year, 1990-2010 and Forecast 2020-2050
    • Figure 2-5: China Life Expectancy at Birth in Years, 2010-2050
    • Table 2-2 : Elderly Dependency Ratio in China and Other Select Countries, 2010 and 2050
  • Disease Demographics
  • Diabetes
  • Cancer
    • Table 2-6: Top 5 Cancers Affecting Chinese Population (ranked by total number of cases), 2010-2017
  • Cardiovascular Disease
  • Infectious Disease Threats
  • Hepatitis
  • HIV/AIDS
  • Tuberculosis
  • Chinese Economy
    • Figure 2-7: China GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)

Chapter Three: Clinical Laboratory Structure in China

  • Clinical Laboratory Tests
  • Test Types
    • Table 3-1 : Types of IVD and Clinical Laboratory Tests, 2018
  • Venues for Test Usage
    • Figure 3-1: Utilization of Beds in Medical Institutions: China's Average Length of Stay is Increasing Slightly, 1985-2016
    • Figure 3-2: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015
  • Urban vs. Rural IVD Market
    • Table 3-2: China In Vitro Diagnostic Reagent Sales by Urban/Rural Environment, 2017
    • Figure 3-3: Province-level Administrative Divisions of China
    • Table 3-3: Per Capita IVD Expenditures by China Province/Region, 2017 (Guangdon, Shangdon, Henan
  • Sichuan, Jiangsu, Hebei, Hunan, Anhui, Hubei, Zhejiang, Others)
    • Figure 3-4: China IVD Market by Province/Region
  • Chinese Healthcare Reform and Hospital Infrastructure
  • China Regulation and Medical Device Policy Challenges
  • Distribution in China
  • Medical Device Regulation Overview: China

Chapter Four: IVD Markets in China

  • Market Introduction and Summary
    • Table 4-1: China In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening, POC Glucose, POC Other, ID/AST, Microbiology Molecular, PT/INR Lab, Blood Group/Typing, Blood Type Molecular, HPV, CTC, Others)
    • Figure 4-1: China In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
    • Figure 4-2: China In Vitro Diagnostic Sales by Market Segment, 2017 Market Distribution (%)
  • Clinical Chemistry
    • Figure 4-3: China - Clinical Chemistry IVD Market, 2017-2022
    • Table 4-2: China - Clinical Chemistry IVD Market Distribution, 2017-2022 (%)
    • Figure 4-4: China - Clinical Chemistry IVD Market Value by Segment, 2017 vs. 2022
  • Point-of-Care (POC) Testing
    • Figure 4-5: China - Point-of-Care IVD Market, 2017-2022
    • Table 4-3: China - Point-of-Care IVD Market Distribution, 2017-2022 (%)
    • Figure 4-6: China - Point-of-Care IVD Market Value by Segment, 2017 vs. 2022
  • Immunoassays
    • Figure 4-7: China - Immunoassay IVD Market, 2017-2022
    • Table 4-4: China - Immunoassay IVD Market Distribution, 2017-2022 (%)
    • Figure 4-8: China - Immunoassay IVD Market Value by Segment, 2017 vs. 2022
  • Molecular Assays
    • Figure 4-9: China - Molecular Assay IVD Market, 2017-2022
    • Table 4-5: China - Molecular Assay IVD Market Distribution, 2017-2022 (%)
    • Figure 4-10: China - Molecular Assay IVD Market Value by Segment, 2017 vs. 2022
    • Table 4-6: HIV Statistics in China, 2016
  • Hematology
    • Figure 4-11: China - Hematology IVD Market, 2017-2022
  • Coagulation
    • Figure 4-12: China - Coagulation IVD Market, 2017-2022
  • Microbiology
    • Table 4-7: China Infectious Disease Classification Tier, December 2017 Impact
    • Figure 4-13: China - Microbiology IVD Market, 2017-2022
    • Table 4-8: China - Microbiology IVD Market Distribution, 2017-2022 (%)
    • Figure 4-14: China - Microbiology IVD Market Value by Segment, 2017 vs. 2022
  • Tests Used in Blood Banking
    • Figure 4-15: China - Blood Bank Test IVD Market, 2017-2022
    • Table 4-9: Prevalence of Transfusion-transmissible Infections in Blood Donations (Median, Interquartile range (IQR), by Income Group
  • Histology and Cytology
    • Figure 4-16: China - Histology/Cytology IVD Market, 2017-2022
    • Table 4-10: China - Histology/Cytology IVD Market Distribution, 2017-2022 (%)
    • Figure 4-17: China - Histology/Cytology IVD Market Value by Segment, 2017 vs. 2022
  • Prenatal and Genetic Test Services

Chapter Five: Company Activity in China

  • China IVD Market Participant Overview
  • Abbott Laboratories
  • Arkray
  • Becton, Dickinson & Co.
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Danaher Corp.
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • Qiagen N.V.
  • Roche
  • Shanghai Kehua Bio-engineering
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific

Appendix:

  • Sources of Information

IVD IN SOUTH KOREA

Chapter 1: Executive Summary

  • Industry Overview
  • Scope and Methodology
  • South Korea IVD Market Summary
    • Figure 1-1: South Korea In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)

Chapter 2: South Korea Overview

  • Population
    • Table 2-1: Total Midyear Population by Broad Age Group: South Korea (million persons), 2010-2050
    • Figure 2-1: Total Midyear Population by Broad Age Group: South Korea (million persons), 2010-2050
    • Figure 2-2: Total Number of Births in South Korea by Year, 1990-2010 and Forecast 2020-2050
    • Figure 2-3: South Korea Life Expectancy at Birth in Years, 2010-2050
  • Health Indicators
  • General Health
  • Disease Profiles in South Korea
    • Table 2-2: Top 5 Cancers Affecting South Korean Population (ranked by total number of cases),
  • 2008-2015
  • Economy and Health Spending
    • Figure 2-4: South Korea GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
    • Figure 2-5: South Korea Distribution of Income or Consumption by Quintile, 2007-2012
  • Health Infrastructure
  • Medical Facilities
    • Figure 2-6: South Korea JCI-Accredited Facilities, 2000-2018
    • Figure 2-7: Hospital Bed Density per 1,000 Population by Country, 2017 Estimates
  • Physicians
    • Figure 2-8: Physician Density per 1,000 Population by Country, 2017 Estimates
  • Medical Device Regulation
    • Table 2-3: Market Divers and Inhibitors for Entering South Korea's Medical Device Market

Chapter 3: IVD Markets in South Korea

  • Market Summary
    • Table 3-1: South Korea In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
    • Figure 3-1: South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017-2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
    • Figure 3-2: South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017 Market Distribution (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other) (%)
  • Clinical Chemistry
    • Figure 3-3: South Korea - Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis), 2017-2022
  • Immunoassay
    • Figure 3-4: South Korea - Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017-222
  • Microbiology/Molecular
    • Figure 3-5: South Korea Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2017-2022
  • Point-of-Care
    • Figure 3-6: South Korea POC Market Value by Segment (Glucose, Infectious Disease, Other), 2017-2022
  • Histology
    • Figure 3-7: South Korea - Histology Market (HPV, CTC, Others), 2017-2022

IVD IN VIETNAM

Chapter 1: Executive Summary

  • Industry Overview
  • Scope and Methodology
  • Vietnam IVD Market Summary
    • Figure 1-1: Vietnam In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)

Chapter 2: Vietnam Overview

  • Population
    • Table 2-1: Total Midyear Population by Broad Age Group: Vietnam (million persons), 2010-2050
    • Figure 2-1: Total Midyear Population by Broad Age Group: Vietnam (million persons), 2010-2050
    • Figure 2-2: Total Number of Births in Vietnam by Year, 1990-2010 and Forecast 2020-2050
    • Figure 2-3: Vietnam Life Expectancy at Birth in Years, 2010-2050
  • Health Indicators
  • General Health
  • Disease Profiles in Vietnam
    • Table 2-2: Top 5 Cancers Affecting Vietnamese Population (ranked by total number of cases), 2010-2015
  • Economy and Health Spending
    • Figure 2-4: Vietnam GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
    • Figure 2-5: Vietnam Distribution of Income or Consumption by Quintile, 2001-2014
  • Health Infrastructure
  • Medical Facilities
    • Figure 2-6: Hospital Bed Density per 1,000 Population by Country, 2017 Estimates
  • Physicians and Health Professionals
    • Figure 2-7: Physician Density per 1,000 Population by Country, 2017 Estimates
  • Medical Device Regulation
    • Table 2-3: Market Divers and Inhibitors for Entering Vietnam's Medical Device Market

Chapter 3: IVD Markets in Vietnam

  • Market Summary
    • Table 3-1: Vietnam In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
    • Figure 3-1: Vietnam In Vitro Diagnostic Sales by Broad Market Segment, 2017 - 2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
    • Figure 3-2: Vietnam In Vitro Diagnostic Sales by Broad Market Segment, 2017 Market Distribution (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other) (%)
  • Clinical Chemistry
    • Figure 3-3: Vietnam - Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis),
  • 2017 - 2022
  • Immunoassay
    • Figure 3-4: Vietnam - Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017 - 2022
  • Microbiology/Molecular
    • Figure 3-5: Vietnam - Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular),
  • 2017 - 2022
  • Point-of-Care
    • Figure 3-6: Vietnam - POC Market Value by Segment (Glucose, Infectious Disease, Others), 2017 - 2022
  • Histology
    • Figure 3-7: Vietnam - Histology Market (HPV, CTC, Others), 2017 - 2022
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Arkray
  • Becton, Dickinson & Co.
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Danaher Corp.
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • Qiagen N.V.
  • Roche
  • Shanghai Kehua Bio-engineering
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll